CAPNETZ: The competence network for community-acquired pneumonia (CAP);CAPNETZ: Das Kompetenzzentrum für ambulant erworbene Pneumonie

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 59, Issue 4, 2016, Pages 475-481

  Suttorp, Norbert ^a   Welte, Tobias ^b   Marre, Reinhard ^c   Stenger, Steffen ^c   Pletz, Mathias ^d   Rupp, Jan ^e   Schütte, Hartwig ^f   Rohde, Gernot ^g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f KLINIKUM ERNST VON BERGMANN   (Germany)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarker; Community acquired pneumonia (CAP); Competence network; Foundation; Health services research

Indexed keywords

CLINICAL COMPETENCE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; GERMANY; GOVERNMENT; HEALTH CARE QUALITY; HUMAN; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PNEUMONIA, BACTERIAL; PROGRAM EVALUATION; PUBLIC RELATIONS;

BIOMEDICAL RESEARCH; CLINICAL COMPETENCE; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FOUNDATIONS; GERMANY; GOVERNMENT PROGRAMS; HUMANS; INTERINSTITUTIONAL RELATIONS; MODELS, ORGANIZATIONAL; ORGANIZATIONAL OBJECTIVES; PNEUMONIA, BACTERIAL; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE;

EID: 84961214065     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-016-2318-7     Document Type: Article

References (42)

1. Welte T, Torres A, Nathwani D (2012) Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71–79
2. Ewig S, Birkner N, Strauss R et al (2009) New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 64:1062–1069
3. Welte T, Kohnlein T (2009) Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network. Semin Respir Crit Care Med 30:127–135
4. Unicef (2006) Pneumonia – the forgotten killer of children. UNICEF/WHO, New York, (ISBN-10:92-806-4048-8)
5. Welte T, Suttorp N, Marre R (2004) CAPNETZ-community-acquired pneumonia competence network. Infection 32:234–238
6. Opitz B, Püschel A, Schmeck B et al (2004) Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J Biol Chem 279:3626–3632
7. Bauer TT, Ewig S, Marre R et al (2006) CAPNETZ Study Group. CRB-65 predicts death from community-acquired pneumonia. J Intern Med 260:93–101
8. Kolditz M, Ewig S, Schutte H et al (2015) Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. J Intern Med 278:193–202
9. Kolditz M, Ewig S, Klapdor B et al (2015) Community-acquired pneumonia as medical emergency: predictors of early deterioration. Thorax 70:551–558
10. Welte T, Marre R, Suttorp N (2006) Kompetenznetzwerk “Ambulant Erworbene Pneumonie” (CAPNETZ). What is new in the treatment of community-acquired pneumonia? Med Klin (munich) 101:313–320
11. Bierbaum S, Konigsfeld N, Besazza N et al (2012) Performance of a novel microarray multiplex PCR for the detection of 23 respiratory pathogens (SYMP-ARI study). Eur J Clin Microbiol Infect Dis 31:2851–2861
12. Pauls S, Krüger S, Richter K et al (2007) Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia. Rofo 179:1152–1158
13. Krüger S, Pletz MW, Rohde G (2011) Biomarker bei ambulant erworbener Pneumonie – was haben wir aus CAPNETZ gelernt? Pneumologie 65(02):110–113
14. Krüger S, Ewig S, Marre R (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31:349–355
15. Krüger S, Ewig S, Giersdorf S et al (2010) Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German competence network, CAPNETZ. Am J Respir Crit Care Med 182:1426–1434
16. Krüger S, Papassotiriou J, Marre R et al (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 33:2069–2078
17. Krüger S, Ewig S, Kunde J (2009) Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment: results from the German competence network CAPNETZ. J Antimicrob Chemother 64:159–162
18. Lepper PM, Ott S, Nuesch E et al (2012) Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 344:e3397
19. Krüger S, Ewig S, Giersdorf S et al (2014) Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ. Respir Med 108:1696–1705
20. Kolditz M, Hoffken G, Martus P et al (2012) Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. Bmc Infect Dis 12:90
21. Pletz MW, von Baum H, van der Linden M et al (2012) The burden of pneumococcal pneumonia – experience of the German competence network CAPNETZ. Pneumologie 66:470–475
22. Dumke R, Schnee C, Pletz MW et al (2015) Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia. Germany 2011–2012. Emerg Infect Dis 21:426–434
23. von Baum H, Ewig S, Marre R et al (2008) Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 46:1356–1364
24. von Baum H, Welte T, Marre R et al (2010) Community-acquired pneumonia through enterobacteriaceae and pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J 35:598–605
25. Schack M, Sachse S, Rodel J et al (2014) Coxiella burnetii (Q fever) as a cause of community-acquired pneumonia during the warm season in Germany. Epidemiol Infect 142:1905–1910
26. von Baum H, Schweiger B, Welte T et al (2011) How deadly is seasonal influenza-associated pneumonia? The German competence network for community-acquired pneumonia. Eur Respir J 37:1151–1157
27. Schweiger B (2004) Viren als Ursache der ambulant erworbenen Pneumonie. Med Welt 55:327
28. Kothe H, Bauer T, Marre R et al (2008) Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32(1):139–146
29. Klapdor B, Ewig S, Schaberg T et al (2012) Presentation, etiology and outcome of pneumonia in younger nursing home residents. J Infect 65:32–38
30. Ewig S, Klapdor B, Pletz MW et al (2012) Nursing-home-acquired pneumonia in Germany: an 8‑year prospective multicentre study. Thorax 67:132–138
31. Kohlhammer Y, Schwartz M, Raspe H et al (2005) Risk factors for community acquired pneumonia (CAP). A systematic review. Dtsch Med Wochenschr 130:381–386
32. Schnoor M, Klante T, Beckmann M et al (2007) Risk factors for community-acquired pneumonia in German adults: the impact of children in the household. Epidemiol Infect 135:1389–1397
33. Tessmer A, Welte T, Schmidt-Ott R et al (2011) Influenza vaccination is associated with reduced severity of community-acquired pneumonia. Eur Respir J 38(1):147–153
34. Pletz MW, Terkamp C, Schumacher U et al (2014) Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res 15:53 doi:10.1186/1465-9921-15-53
35. Tessmer A, Welte T, Martus P et al (2009) Impact of intravenous ß‑lactam/macrolide versus ß‑lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother 63:1025–1033
36. Höffken G, Lorenz J, Kern W et al (2009) Epidemiologie, Diagnostik, antimikrobielle Therapie und Management von erwachsenen Patienten mit ambulant erworbenen unteren Atemwegsinfektionen sowie ambulant erworbener Pneumonie – Update 2009. Pneumologie 63:e1–e68
37. Ewig S, Höffken G, Kern WV, Rohde G, Flick H, Krause R, Ott S, Bauer T, Dalhoff K, Gatermann S, Kolditz M, Krüger S, Lorenz J, Pletz M, de Roux A, Schaaf B, Schaberg T, Schütte H, Welte T (2016) S3-Leitlinie-Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention – update 2015. Pneumologie (in press)
38. Schnoor M, Meyer T, Suttorp N et al (2010) Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care 19:498–502
39. Rohde GG, Koch A, Welte T et al (2015) Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD-the ABACOPD study. BMC Pulm Med 15:5
40. Suttorp N() Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis. www.progress-net.de
41. Löffler M, Suttorp N (2015) CAPSyS Systems Medicine of Community Acquired Pneumonia. (Institut für Medizinische Informatik, Statistik und Epidemiolgie, Universität Leipzig 2014) www.capsys.imise.uni-leipzig.de/index.jsp. Zugegriffen: 27.7.2015
42. Suttorp N () Innate Immunity of the lung. www.sfb-tr84.de